Seres Therapeutics to present SER-428 preclinical data at IDWeek
Tweet Send to a Friend
Seres Therapeutics, Inc. (Nasdaq: MCRB) announced it will present preclinical data for SER-428, an investigational oral liquid live biotherapeutic product ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




